Loratadine And Pseudoephedrine Sulfate Tablet, Film Coated, Extended Release
Product Images NDC 0904-5833

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Loratadine And Pseudoephedrine Sulfate (NDC 0904-5833). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (240 mg/10 mg Tablet Blister Pack Carton)

Packaging label for Loratadine and Pseudoephedrine Sulfate Extended-Release Tablets by Major Pharmaceuticals. Each tablet contains 10 mg Loratadine and 240 mg Pseudoephedrine Sulfate. The box includes 10 film-coated tablets for oral use, indicated for allergy and congestion relief, providing 24-hour non-drowsy symptom control. The label highlights indoor and outdoor allergy relief and lists common symptoms addressed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.